Images
Participants
Contact
The leader of the Colorectal Cancer Lab will give a plenary lecture at EACR-23
The European Association for Cancer Research (EACR) has announced today that Eduard Batlle is the winner of the Pezcoller Foundation – EACR Cancer Researcher Award.
The award, presented biennially to a researcher of excellence with no more than 15 years post-doctoral experience, celebrates academic excellence and achievements in the field of cancer research.
Eduard Batlle will give the prestigious Pezcoller Foundation – EACR Award Lecture at the 23rd European Association for Cancer Reserach (EACR) in Munich, 5th – 8th July 2014.
The Pezcoller Foundation is a non-profit organisation created in 1980 by Prof. Alessio Pezcoller (1896 - 1993), Chief Surgeon of Santa Chiara Hospital of Trento, Italy. The goal of the Foundation is to promote biomedical research in the field of cancer.
Since 2005, Eduard Batlle coordinates the Oncology Programme and directs the Colorectal Cancer Laboratory Group at IRB Barcelona. Batlle holds a prestigious European Research Council (ERC) Starting Grant and more recently was awarded an ERC Advanced Grant to pursue his research into intestinal stem cells and colon cancer.
Brief profile:
Eduard Batlle (Barcelona, 1970), received a doctorate in biology from the University of Barcelona. His first postdoctoral position was at the Institut für Molekularbiologie und Tumorforschung, in Marburg, Germany, and then he spent four years at the Netherlands Institute for Developmental Biology, in Utrecht, The Netherlands, under the mentorship of the renowned scientist Hans Clevers.
His work has been published in the best biomedical journals, including several articles in Nature journals and deserving two covers in Cell and Cancer Cell.
Some of the discoveries made by Eduard Batlle have founded new fields of research, and his publications have a high impact in the scientific community, as reflected by the citations and comments they have received in leading scientific journals.
Dr. Batlle holds several prizes, including the Debiopharm Life Sciences Award for Outstanding Research in Oncology from the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland (2006), the Banc Sabadell Biomedical Research Award (2010), Dr. Josef Steiner Cancer Research Award (2013) and “Doctores Diz Pintado” National Cancer Research Prize (2014).
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
